AMPH — Amphastar Pharmaceuticals, Share News
0.000.00%
Last trade - 00:00- $885.83m
- $1.21bn
- $719.89m
Brief: Amphastar Pharmaceuticals Authorizes $50 Mln Increase To Share Buyback Program
India's Lupin falls on fears of market share loss for respiratory drug in US
Amphastar Pharmaceuticals Inc expected to post earnings of 77 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Bark, Fleetcor Technologies, Tesla
Amphastar Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Amphastar Pharmaceuticals Inc expected to post earnings of 91 cents a share - Earnings Preview
Amphastar Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Amphastar Pharmaceuticals Inc expected to post earnings of 56 cents a share - Earnings Preview
Amphastar up after Piper Sandler raises PT
U.S. RESEARCH ROUNDUP-Adobe, Apple, Pinterest
Brief: Amphastar Pharmaceuticals Inc Says Entered Into A Credit Agreement
U.S. RESEARCH ROUNDUP-Denbury, Domino's Pizza, Tesla
U.S. RESEARCH ROUNDUP-Axon Enterprise, RingCentral, Roblox
Amphastar Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Amphastar Pharmaceuticals posts Q1 EPS USD 0.5
Amphastar Pharmaceuticals Inc expected to post earnings of 48 cents a share - Earnings Preview
Deals of the day-Mergers and acquisitions
Amphastar Pharma slips on deal to buy Eli Lilly's low blood sugar drug
Deals of the day-Mergers and acquisitions